Andrea Knight, MD, MSCE
Hospital for Sick Children
Toronto, Ontario, Canada
Disclosure(s): Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, May 27, 2023)
Carla Cuda, PhD
Northwestern University
Chicago, IL, United States
Disclosure information not submitted.
Teresa Tarrant, MD
Duke University
Durham, North Carolina, United States
Disclosure(s): Amgen: Grant/Research Support (Ongoing); Chiesi: Consultant (Ongoing), Grant/Research Support (Ongoing); Department of Justice: Consultant (Ongoing); X4 Pharmaceuticals: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing)
Innate immune responses are essential for host defense from viral pathogenesis and cellular damage and must be tightly regulated to avoid excessive inflammation or autoimmunity. Recent scientific discovery has shown that fibrinogen deposits in the lungs and brains of patients with SARS-CoV-2 infection correlate with disease severity and predict long COVID cognitive deficits. Other mechanisms contributing and lending to therapeutic intervention include alterations in the microbiome. Given the complexity of overlapping mechanisms between antiviral immunity and autoimmunity, machine learning and modeling techniques may provide new insights for treatment and pathogenesis.
Speaker: Zhaoqi Yan, PhD – Gladstone Institute of Neurological Disease
Speaker: Linda Geng, MD, PhD – Stanford University